News

VerZom achieves first bioproduction of clinical grade stem cell-derived...

EVerZom, a biopharmaceutical company developing  exosome based biodrugs, announces that it has reached a key milestone in its development with the production of a first exosome GMP batch in a 10L bioreactor with unprecedented...

Emmes awarded multi-task, IDIQ contract with $50M ceiling, to...

Emmes, part of Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), has been selected by the National Institutes of Health’s (NIH) NIDA to support their Clinical Trials Network (CTN) for a multi-task, IDIQ contract. The...

Revolutionizing Drug Valuation With Real-World Evidence

Determining the value of a medicine may be a challenging task. To put it another way, how much is the value of a patient's life?...

Role of AI In Transforming Drug Discovery And Development

Artificial Intelligence (AI) is transforming the pharmaceutical industry, driving significant advancements across various stages of drug discovery, development, and production. By leveraging AI technologies, pharmaceutical...

AI-Driven Route Scouting Revolutionizes Drug Development

Lonza is revolutionizing drug development with its AI-driven route scouting technology, allowing pharmaceutical companies to fast-track their investigational new drug (IND) submissions. By integrating artificial...

Innovations In Biologic Drug Delivery Beyond Injections

Despite their track record of demonstrating significant therapeutic efficacy, biologics still face daunting challenges in their drug delivery. Biologics such as monoclonal antibodies (mAbs) and...

Pharma Future : Innovations In Drug Delivery Nanoparticles

The pharmaceutical sector is still a hub for new patent developments. The development of novel treatment paradigms, the severity of unfulfilled requirements, and the increasing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read